Allergy & Clinical Immunology News
- Alert EU Approves Bimekizumab for PsA and AxSpA
- Is ChatGPT a Friend or Foe of Medical Publishing?
- Antibody Linked to Spontaneous Reversal of ATTR-CM
- Advances in HIV Vaccine Research Show Promise for Prevention
- Long COVID Risk Not Higher With Rheumatic Diseases
- Lung Cancer Device Study Raises Concerns for Commercial Use
- Merck Sues US Government to Halt Medicare Drug Price Negotiation
- Should Antibiotic Treatment Be Used Toward the End of Life?
- Risk for Incident VTE Increased in Adults With AD
- Alert FDA OKs Letermovir to Prevent CMV in Kidney Transplants
- Dupilumab Outcomes Stable in Open-Label AD Study
- Abrocitinib Improvements Sustained in AD Extension Study
- ASCO 2023 Safe to Stop Immunotherapy at 2 Years in Stable Lung Cancer
- CMSC 2023 Multiple Changes in NMOSD Treatment Tied to Poorer Outcomes
- When Could You Be Sued for AI Malpractice? You're Likely Using It Now
- CMSC 2023 Mindfulness-Based Stress Reduction Program Benefits MS
- How Fat Burden May Affect IBD Drug Dosing
- Choosing SPF Is Only the Start When Recommending Sunscreens
- 7 Tactics to Reduce EHR Tasks and Save Time
- MDs With Chronic Illness Live in a Different Medical World